The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 334:913-914 April 4, 1996 Number 14
NextNext

Injection Therapy for Erectile Dysfunction

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
In this issue of the Journal, Linet and Ogrinc report that intracavernous-injection therapy with alprostadil (a synthetic prostaglandin E1) can produce good results in men with erectile dysfunction (impotence).1 It should be emphasized that the proper treatment of such men requires individualized evaluation and depends on the cause of their erectile dysfunction. The first step in management of erectile dysfunction is a comprehensive investigation that begins with a thorough medical history and physical examination. The causes are diverse and may be hormonal, psychological, vasculogenic, or neurogenic. Medications, especially antihypertensive and psychotropic drugs, can also cause impotence. Commonly, serum testosterone . . . [Full Text of this Article]



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.